Immunome ($IMNM) Insider Trading & Smart Money Activity

Immunome, Inc. · Biotechnology · Latest filing Jun 25, 2026

Immunome, Inc. ($IMNM) has 3 insider trades and 2 analyst ratings on file. Insiders filed 3 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
2

IMNM insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All IMNM insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Robert LechleiderChief Medical Officer Sell (Option exercise) 55K sh +21.7%+16.4% Read
Insider Robert LechleiderChief Medical Officer Buy (Option exercise) 55K sh $480.15K +21.7%+16.4% Read
Insider Max RosettChief Financial Officer Sell (Option exercise) 60K sh +6.1%+26.8% Read
Analyst Wedbush Reiterates to buy PT $31 +4.4%+24.0% Read
Analyst Wedbush Reiterates to buy PT $31 +4.4%+24.0% Read

1W / 1M / 6M = how IMNM moved from the trade or filing date.

Insider trading in IMNM: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Robert Lechleider Chief Medical Officer 2 — Jun 25, 2026
Max Rosett Chief Financial Officer 1 — Jun 15, 2026

Analyst ratings on IMNM

DateFirmActionRatingPrice target1W1M6MStory
Wedbush Reiterates buy $31 +4.4%+24.0% Read
Wedbush Reiterates buy $31 +4.4%+24.0% Read

Frequently asked questions

What is the latest insider trade in IMNM?

Robert Lechleider, Chief Medical Officer filed a sell (option exercise) of 55K sh on Jun 25, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text